Research Article

Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis

Volume: 4 Number: 4 December 30, 2025
TR EN

Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis

Abstract

Epidemiological and clinical analyses of brucellosis are vital for strengthening disease surveillance and case management strategies. This study aimed to evaluate the epidemiological characteristics of human brucellosis by seasonal distribution and year, and to determine brucellosis seropositivity in the region. A retrospective analysis was conducted of 4,510 suspected cases presented to Nevşehir State Hospital between 2013 and 2023.The Rose Bengal test (RBT) was used for screening, and RBT-positive sera were evaluated with a standard tube agglutination test. Titers ≥1/160 were considered diagnostic. Of the 4510 patients, 405 (8.98%) were RBT positive, and 143 (35.3%) were confirmed with STA titers ≥1/160, for an overall seropositivity rate of 3.18% (95% CI: 2.7-3.7). The majority were male (72.7%), and the mean age was 35.4 years. Most cases were linked to animal contact, with the incidence peaking in the summer months. A sharp increase was observed in 2022. Our findings demonstrate the prevalence of human brucellosis among patients with a pre-diagnosis of brucellosis in Nevşehir, influenced by occupational and seasonal factors. Strengthening animal vaccination, public awareness, and diagnostic capacity are essential to reduce the disease burden and improve surveillance. This study provides important regional data to guide control strategies.

Keywords

Brucellosis, Epidemiology, Laboratory diagnosis, Zoonosis

Ethical Statement

The study protocol was conducted in accordance with the Declaration of Helsinki, and the research was approved by the Kapadokya University Research Ethics Committee (approval date: October 16, 2024; approval code: G.O. 24/2024).

References

  1. Di Bonaventura G, Angeletti S, Ianni A, Petitti T, Gherardi G. Microbiological laboratory diagnosis of human brucellosis: an overview. Pathogens. 2021;10(12):1623.
  2. Song J, Hu X, Li X, et al. Rickettsia burneti and Brucella melitensis co-infection: a case report and literature review. BMC Microbiol. 2021;21(1):270.
  3. Khan I, Ali S, Hussain R, et al. Serosurvey and potential risk factors of brucellosis in dairy cattle in peri-urban production system in Punjab, Pakistan. Pak Vet J. 2021;41:459-462.
  4. Bagheri Nejad R, Krecek RC, Khalaf OH, Hailat N, Arenas-Gamboa AM. Brucellosis in the Middle East: Current situation and a pathway forward. PLoS Negl Trop Dis. 2020;14(5):e0008071.
  5. Byndloss MX, Tsolis RM. Brucella ssp. Virulence factors and immunity. Annu Rev Anim Biosci. 2016;4(1):111-127.
  6. Occhialini A, Hofreuter D, Ufermann CM, Al Dahouk S, Köhler S. The retrospective on atypical Brucella species leads to novel definitions. Microorganisms. 2022;10(4):813.
  7. Rabah IM, Nossair M, Elkamshishi MM, Khalifa E. Serological and molecular epidemiological study on ruminant brucellosis in Matrouh Province, Egypt. Int J Vet Sci. 2022;11:82-90.
  8. Jamil T, Khan AU, Saqib M, et al. Animal and human brucellosis in Pakistan. Front Public Health. 2021;9:660508.
  9. Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007;7(12):775-786.
  10. About F, Pastre T, Boutrou M, et al. Novel species of Brucella causing human brucellosis, French Guiana. Emerg Infect Dis. 2023;29(2):333-340.
APA
Akman, N., & Karat, E. (2025). Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis. Farabi Medical Journal, 4(4), 124-131. https://doi.org/10.59518/farabimedj.1740228
AMA
1.Akman N, Karat E. Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis. Farabi Medical Journal. 2025;4(4):124-131. doi:10.59518/farabimedj.1740228
Chicago
Akman, Nazife, and Erhan Karat. 2025. “Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis”. Farabi Medical Journal 4 (4): 124-31. https://doi.org/10.59518/farabimedj.1740228.
EndNote
Akman N, Karat E (December 1, 2025) Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis. Farabi Medical Journal 4 4 124–131.
IEEE
[1]N. Akman and E. Karat, “Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis”, Farabi Medical Journal, vol. 4, no. 4, pp. 124–131, Dec. 2025, doi: 10.59518/farabimedj.1740228.
ISNAD
Akman, Nazife - Karat, Erhan. “Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis”. Farabi Medical Journal 4/4 (December 1, 2025): 124-131. https://doi.org/10.59518/farabimedj.1740228.
JAMA
1.Akman N, Karat E. Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis. Farabi Medical Journal. 2025;4:124–131.
MLA
Akman, Nazife, and Erhan Karat. “Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis”. Farabi Medical Journal, vol. 4, no. 4, Dec. 2025, pp. 124-31, doi:10.59518/farabimedj.1740228.
Vancouver
1.Nazife Akman, Erhan Karat. Evaluation of Seropositive Brucellosis Cases in Nevşehir, Türkiye: An 11-Year Analysis. Farabi Medical Journal. 2025 Dec. 1;4(4):124-31. doi:10.59518/farabimedj.1740228